1. Home
  2. CLW vs CUVL Comparison

CLW vs CUVL Comparison

Compare CLW & CUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clearwater Paper Corporation

CLW

Clearwater Paper Corporation

HOLD

Current Price

$19.04

Market Cap

338.7M

ML Signal

HOLD

Logo Clinuvel Pharmaceuticals Limited American Depositary Shares

CUVL

Clinuvel Pharmaceuticals Limited American Depositary Shares

N/A

Current Price

$5.00

Market Cap

374.2M

Sector

Miscellaneous

ML Signal

N/A

Company Overview

Basic Information
Metric
CLW
CUVL
Founded
1926
1999
Country
United States
Australia
Employees
3710
16
Industry
Paper
Miscellaneous
Sector
Basic Materials
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
338.7M
374.2M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
CLW
CUVL
Price
$19.04
$5.00
Analyst Decision
Hold
Analyst Count
4
0
Target Price
★ $22.25
N/A
AVG Volume (30 Days)
★ 98.7K
4.9K
Earning Date
10-26-2026
08-27-2026
Dividend Yield
N/A
★ 0.56%
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $1,555,400,000.00
N/A
Revenue This Year
N/A
$0.89
Revenue Next Year
$4.20
$6.69
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 12.42
N/A
52 Week Low
$11.73
$4.91
52 Week High
$23.59
$8.20

Technical Indicators

Market Signals
Indicator
CLW
CUVL
Relative Strength Index (RSI) 45.61 30.44
Support Level $18.13 $4.91
Resistance Level $19.09 $6.04
Average True Range (ATR) 0.77 0.15
MACD -0.01 -0.02
Stochastic Oscillator 42.98 10.09

Price Performance

Historical Comparison
CLW
CUVL

About CLW Clearwater Paper Corporation

Clearwater Paper Corp is engaged in the manufacturing and supplier of Solid Bleached Sulfate (SBS) paperboard packaging products. The company products includes: SBS paperboard which is a premium paperboard grade that is frequently used to produce folding cartons, food service, commercial printing items. It generates maximum revenue from Pulp and Paperboard segment. Company operate in United States and have globalized access too. Geographically, it derives maximum revenue from the United States.

About CUVL Clinuvel Pharmaceuticals Limited American Depositary Shares

Clinuvel distributes a single product, Scenesse, the only approved treatment for phototoxic reactions specifically associated with a rare genetic disease called erythropoietic protoporphyria. EPP causes extreme pain or burns from brief exposure to light, affecting a patient's quality of life. Scenesse is a patented dissolvable implant, comparable in size with a rice grain, injected underneath the skin roughly every three months for ongoing protection. The implant controls the release of a synthetic drug which promotes the production of more melanin, thereby reducing pain and increasing tolerance for light exposure. The majority of Clinuvel's earnings stem from Europe and the US.

Share on Social Networks: